Century Therapeutics Inc — Cash Flow (NASDAQ:IPSC) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -89 M14.05 M-88.35 M-110.14 M-103.88 M -103.88 M Cash from investing activities -298.34 M-13.13 M61.13 M47.48 M107.5 M 107.5 M Cash from financing activities 417.77 M27.16 M-9.72 M74.56 M173 K 173 K Free cash flow -133.97 M-16.55 M-102.08 M-110.29 M-104.72 M -104.72 M

Nouvelles

Century Therapeutics actualise son programme d’émission d’actions avec 131,6 millions de dollars restants

Leerink réitère sa note Market Perform sur Century Therapeutics

Leerink reiterates Market Perform on Century Therapeutics stock

TD Cowen initie la couverture de Century Therapeutics avec une recommandation d’achat

TD Cowen initiates Century Therapeutics stock rating at Buy

Clear Street réitère sa recommandation d’achat sur Century Therapeutics à 6,60€

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

L’objectif de prix de Century Therapeutics abaissé à 6,60€ par Clear Street

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics secures $135 million in private placement